Latest Medical Imaging News

Blue Star Helium has reported strong flow test results from its Bubba State 3 well in Lincoln County, Colorado, confirming helium concentrations around 2.01% and robust production rates that support further development.

Optiscan Imaging Ltd has revealed its next-generation InForm™ pathology imaging device and strengthened its executive team, while reporting a robust cash position supported by a $1.775 million R&D tax refund for the quarter ended 31 March 2025.

CurveBeam AI reported a robust 40% increase in purchase orders during Q3 FY25 and secured a non-binding A$18 million vendor financing term sheet, positioning the company for cashflow positivity in Q4.

Mach7 Technologies reported a robust Q3 FY25 with a CARR of A$30.8 million and positive operating cash flow, while announcing a leadership change and reaffirming growth guidance.

Micro-X Ltd has secured a $5.6 million strategic partnership with Malaysian firm Billion Prima and raised $4 million in capital, marking a pivotal shift towards medical imaging while progressing key security and health technology projects.

Blue Star Helium has reported robust flow rates from multiple development wells and received permitting approval for a helium and CO2 processing plant, advancing its path to first production in H1 2025.

Enlitic has announced a strategic collaboration with GE HealthCare to deploy AI-driven technology that will transform the migration of medical imaging data, promising faster, more secure transitions and enhanced data quality for healthcare providers worldwide.

D3 Energy has secured three new Technical Cooperation Permits near its flagship ER315 project, broadening its footprint in a world-class helium province and setting the stage for potential resource growth.

Pro Medicus has delivered a record first half in FY25, driven by strong revenue growth, major contract wins, and successful implementations that position it well for future expansion.

Pro Medicus Limited has reported a robust half-year financial performance for the period ending December 31, 2024, with net profit soaring 42.7% and an increased interim dividend declared.

Micro-X Limited has initiated a $2.7 million retail entitlement offer as part of a broader $6 million capital raising, supporting its strategic pivot towards medical imaging technologies and strengthening its balance sheet.

Micro-X Ltd has launched the retail component of its $6 million capital raising, offering eligible shareholders the chance to buy new shares at 7 cents each, aiming to raise $2.7 million by late February 2025.